Company: IPSC
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001558370-25-011575
Chunk: 21

Company: Century Therapeutics, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 21
---
AP”) for interim financial information and with the interim period reporting requirements of Form 10-Q and Article 10 of Regulation S-X. The consolidated balance sheet as of June 30, 2025, and the consolidated statements of operations and comprehensive income (loss), consolidated statements of changes in stockholders’ equity, and the consolidated statements of cash flows for the six months ended June 30, 2025 and 2024, are unaudited, but, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, which the Company considers necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The results for any interim period are not necessarily indicative of results for the year ending December 31, 2025 or for any other subsequent interim period. The consolidated balance